Pediatric Cancers: Clinical Trials

Showing 21 - 40 of 81 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055]
O'Reilly, Richard
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075]
Kushner, Brian
  • Neuroblastoma
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096]
Trippett, Tanya
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 11-210]
Trippett, Tanya
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of Sunitinib in Young Patients with Advanced Gastrointestinal Stromal Tumors
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-226]
Magnan, Heather
  • Sarcomas
  • Upper Gastrointestinal
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
[Protocol 95-024]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Blood and Marrow Transplantation
    • Transplantation
  • Leukemia
  • Lymphoma
A Phase I/II Study of Veliparib (ABT-888) Given with Radiation Therapy and then Given with Temozolomide in Children with Newly Diagnosed Diffuse Pontine Glioma
Newly Diagnosed
[Protocol 12-176]
Gilheeney, Stephen
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies
[Protocol 06-125]
Boulad, Farid
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase I/IIA Study of Dabrafenib in Children with Advanced BRAF Mutation-Positive Solid Tumors
[Protocol 13-016]
Pratilas, Christine
  • Melanoma
  • Pediatric Brain Tumors
  • Solid Tumors
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of 5'-Azacitidine to Prevent Recurrence in Patients Who Had a Donated Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndromes
[Protocol 13-192]
Tamari, Roni
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015]
Modak, Shakeel
  • Neuroblastoma
A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016]
Giralt, Sergio
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-086]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-183]
Trippett, Tanya
  • Neuroblastoma
  • Primary Bone
    • Ewing's Sarcoma
  • Sarcomas
    • Ewing's Sarcoma
    • Soft Tissue Sarcoma
A Phase II Study of Dasatinib in Children and Adolescents Newly Diagnosed with Chronic Phase CML or with Philadelphia Chromosome-Positive Leukemias Resistant to or Intolerant of Imatinib
[Protocol 11-030]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Chronic Myelocytic Leukemia
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-211]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission after Non-Myeloablative Therapy in Patients with High-Risk Neuroblastoma
[Protocol 09-159]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
[Protocol 09-160]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in the Bone Marrow
[Protocol 09-161]
Kushner, Brian
  • Neuroblastoma